毛骨悚然撞鬼经

Australia to deepen military ties with Indonesia_我的网站

一 |     近日，杭州医药港传来消息：天境生物研发的注射用菲泽妥单抗（商品名：境斐^[®]），拿到了国家药品监督管理局的上市批准。    Melbourne (Australia), Oct 20 (UNI) Australia says it will continue to provide military training, conduct joint exercises and export weapons to Indonesia despite increased violence and allegations of human rights abuses in West Papua, where conflict has been rumbling for decades.
The Australian Department of Defence confirmed in a statement to Al Jazeera that Anthony Albanese’s government, which was elected in May, would continue to supply arms to Indonesian forces and provide them with military training.
“Indonesia is one of Australia’s most important partners. Australia will continue to conduct joint exercises, provide military and policy training, and – consistent with appropriate legislation – export military equipment to Indonesia,” the statement said.
Despite some rocky patches, Australia has had a longstanding military relationship with Indonesia, including joint training and weapons supply, with Thales Australia selling three Bushmaster troop carriers to Kopassus, Indonesia’s elite forces, in 2014, Al Jazeera reported.
Military units, such as Kopassus, conduct joint training exercises with the Australian SAS, the country’s special forces, while Detachment 88 — also known as Densus 88, a counterterrorism force set up in the wake of the 2002 Bali Bombings — gets funding and training from both Australia and the United States.
Such initiatives have been credited with reducing the threat from hardline groups, but Indonesian forces remain under scrutiny over allegations of serious human rights abuses in West Papua, where Indigenous people have been fighting for independence for 50 years.
Indonesia moved into the resource-rich region in the early 1960s, formalising its control through a controversial, UN-approved referendum in 1969.
Amid armed resistance from West Papuan independence fighters such as the Free Papua Movement, or Organisasi Papua Merdeka (OPM), which reportedly targeted Indonesian civilians, more military and special forces units were sent to the area, the report said.
UNI MR。这款药将联合来那度胺和地塞米松，用于治疗既往至少接受过一线治疗的多发性骨髓瘤成年患者。

二 | 这是该产品在全球范围内的首次获批。境斐^[®]是一款靶向CD38的人源单克隆抗体，整个多发性骨髓瘤适应证的临床开发和注册申报，全部由天境生物在中国完成。“10年前，这些药要等在国外上市了，再引进到中国重新做开发。现在反过来了。”天境生物董事长钱丽丽说。境斐^[®]的获批，让钱塘区今年上市的1类创新药增至3款，数量位列全省第一。截至目前，杭州医药港已集聚生物医药企业1800多家，累计4款1类创新药获批上市。另有138个创新药进入临床试验，数量居杭州市首位，其中14个药品已处于临床三期。

Current article:http://4g9.pisezuibanzoukou.cyou/86j5/98jy.html

Published on:22:00:29